RABELOC

This brand name is authorized in Nigeria.

Active ingredients

The drug RABELOC contains one active pharmaceutical ingredient (API):

1	Rabeprazole UNII 3L36P16U4R - RABEPRAZOLE SODIUM
	Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump).
	Read more about Rabeprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-9003	Tablet	Rabeloc 20 Tablets TAB 20 mg 1 x 10's	Tablet	28/10/2021
A4-0721	Powder for injection	Rabeloc IV Injection INJ_PWD 20 mg 1 x 1's (in vials)	Powder for solution for injection	28/10/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC04	Rabeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-9003, A4-0721